| Exposure to hyperoxemia | Exposure to high FiO2 | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Baseline variables | ||||
Age, years | 1.018(1.014–1.022) |  < 0.001 | 1.018(1.014–1.022) |  < 0.001 |
Male | 0.981 (0.892–1.078) | 0.69 | 0.972 (0.885–1.069) | 0.57 |
Admission type | ||||
Medical | Reference | Â | Reference | Â |
Surgical elective | 0.248 (0.158–0.389 |  < 0.001 | 0.246 (0.157–0.386) |  < 0.001 |
Surgical urgent | 0.846 (0.759–0.943) | 0.024 | 0.834 (0.748–0.929) |  < 0.001 |
Other | 0.643 (0.558–0.742) |  < 0.001 | 0.642 (0.557–0.741) |  < 0.001 |
Weight, kg | 0.993 (0.990–0.994) |  < 0.001 | 0.992 (0.990–0.994) |  < 0.001 |
Elixhauser comorbidity score | 1.033 (1.014–1.052) |  < 0.001 | 1.038 (1.019–1.057) |  < 0.001 |
Time-varying variables | ||||
Receiving IMV | 0.417 (0.375–0.463) |  < 0.001 | 0.437 (0.393–0.486) |  < 0.001 |
Use of vasopressor | 1.370 (1.223–1.534) |  < 0.001 | 1.380 (1.232–1.546) |  < 0.001 |
SOFA score | 1.145 (1.129–1.160) |  < 0.001 | 1.131 (1.116–1.147) |  < 0.001 |
PaCO2, mmHg | 1.016 (1.013–1.020) |  < 0.001 | 1.014 (1.010–1.017) |  < 0.001 |
Any hyperoxemia (TWA-PaO2 ≥ 120 mmHg) | 1.166 (1.059–1.284) | 0.0017 | – | – |
Any exposure to high FiO2 (TWA-FiO2 ≥ 0.5) | – | – | 1.496 (1.363–1.641 |  < 0.001 |